Curis

CRIS

Q2 FY2026 EarningsCRIS missed Q2 FY26 revenue and EPS consensus significantly, reporting zero revenue vs. $0.75M expected following the divestiture of Erivedge. Diluted GAAP EPS was -$4.02, appearing to beat the -$7.11 consensus, but this was primarily driven by a 238% YoY increase in weighted average shares due to massive dilution. Management issued a 'going concern' warning, noting that current cash plus August 2026 offering proceeds will only fund operations into Q4 2026, posing extreme liquidity risk.

Financial report interval: 2026.03.30 - 2026.06.30

Overview: Curis(CRIS) the EBIT is -9.94 M (-20.47%), Beat estimate;the EPS is -4.02 (+70.44%), Beat estimate.

Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
TBA--
0.00B72.72%
----
EBITExceed expectations
-0.01B20.47%
-0.01B27.51%
+0.00B7.04%
EPSExceed expectations
-4.0270.44%
-7.10547.76%
+3.085022.68%

Revenue

ActualEstimateUnit: USD
Quarterly

EBIT

ActualEstimateUnit: USD
Quarterly

Net income

ActualEstimateUnit: USD
Quarterly

EPS

ActualEstimateUnit: USD
Quarterly